|
In three 2-week, multicenter, randomized, double-blind, placebo-controlled trials in subjects 12 to 68 years of age with seasonal allergic rhinitis (n=1634), fexofenadine hydrochloride 60 mg twice daily significantly reduced total symptom scores (the sum of the individual scores for sneezing, rhinorrhea, itchy nose/palate/throat, itchy/watery/red eyes) compared to placebo. Fexofenadine hydrochloride pharmacokinetics are linear for oral doses up to a total daily dose of 240 mg (120 mg twice daily). Radiolabeled tissue distribution studies in rats indicated that fexofenadine does not cross the blood-brain barrier. Symptom reduction was greater with fexofenadine hydrochloride180 mg than with placebo. Fexofenadine hydrochloride is a racemate and exists as a zwitterion in aqueous media at physiological pH. The mechanism of Zyrtec And Allegra interactions has been evaluated in in vitro, in situ, and in vivo animal models. Following oral administration of a 30 mg dose of ALLEGRA Oral Suspension to healthy adult subjects, the mean Cmax was 118.0 ng/mL and occurred at approximately 1.0 hour. Onset of action for reduction in total symptom scores, excluding nasal congestion, was observed at 60 minutes compared to placebo following a single 60 mg fexofenadine hydrochloride dose administered to subjects with seasonal allergic rhinitis who were exposed to ragweed pollen in an environmental exposure unit. It is freely soluble in methanol and ethanol, slightly soluble in chloroform and water, and insoluble in hexane. Moreover, no sedative or other central nervous system effects were observed. Efficacy was demonstrated by a significant reduction in mean pruritus scores (MPS), mean number of wheals (MNW), and mean total symptom scores (MTSS, the sum of the MPS and MNW score). After administration of a single 60 mg capsule to healthy subjects, the mean maximum plasma concentration (Cmax) was 131 ng/mL. The clinical significance of these findings is unknown. In these studies, there was no additional reduction in total symptom scores with higher doses of fexofenadine hydrochloride up to 240 mg twice daily. Following single dose oral administrations of either the 60 and 180 mg tablet to healthy adult male subjects, mean Cmax were 142 and 494 ng/mL, respectively. Although all 4 doses were significantly superior to placebo, symptom reduction was greater and efficacy was maintained over the entire 4-week treatment period with fexofenadine hydrochloride doses of 60 mg twice daily. Fruit juices such as grapefruit, orange and apple may reduce the bioavailability and exposure of fexofenadine Zyrtec And Allegra . The aqueous tablet film coating is made from hypromellose, iron oxide blends, polyethylene Zyrtec And Allegra povidone, silicone dioxide, and titanium dioxide. Fexofenadine hydrochloride, the major active metabolite of terfenadine, is an antihistamine with selective peripheral H1-receptor antagonist activity. In one 4-week, multicenter, randomized, double-blind, placebo-controlled clinical trial in subjects 12 years of age and older with chronic idiopathic urticaria (n=259), fexofenadine hydrochloride 180 mg once daily significantly reduced the mean number of wheals (MNW), the mean pruritus score (MPS), and the mean total symptom score (MTSS, the sum of the MPS and MNW scores). The mean elimination half-life of fexofenadine was 14.4 hours following administration of 60 mg twice daily in healthy subjects.
|